Weil Advises Advent in Purchase of Chinese Bio-Pharma Company

Weil, Gotshal & Manges said it advised Boston-based Advent International on its acquisition of Sundia MediTech Company, Ltd., a contract pre-clinical research and manufacturing organization based in Shanghai.

No terms were disclosed for the deal, on which Bridgewest Capital also participated as co-investor, according to a statement.

Weil called the transaction a “bolt-on acquisition” to Advent’s January 2019 purchase of BioDuro, a San Diego-headquartered life science research and development company.

After the deal closes, BioDuro will combine with Sundia and operate as BioDuro-Sundia. With more than 2,000 employees across 10 global sites, it will be one of the world’s largest ...